Figure 2From: Mechanism-related circulating proteins as biomarkers for clinical outcome in patients with unresectable hepatocellular carcinoma receiving sunitinibPlasma pharmacodynamics of VEGF-C in patients with baseline VEGF-C levels above or below the median value of 822.2 pg/mL. C, cycle; D, day.Back to article page